Modeling the cost-effectiveness of a potential lung cancer screening program for Germany

Health economic modeling of the cost-effectiveness of potential annual screening for lung cancer among heavy smokers. The modeling allows conclusions about the extent to which costs and benefits are appropriately balanced. It also quantifies the budget impact of the potential intervention for decision makers.

• Cooperation partner: Siemens AG